Irritable bowel syndrome and celiac disease share so many symptoms that doctors routinely mistake one for the other. A new prospective study published in Tropical Doctor adds to a growing body of evidence that a significant share of patients diagnosed with IBS actually have undetected celiac disease—and pinpoints the clinical signs that should trigger testing.
The study, conducted by Mayur D, Agarwal A, and Birda CL in Rajasthan, India, enrolled IBS patients and put them through celiac screening. Their goals were to determine how many IBS patients had undiagnosed celiac disease, and to identify which symptoms or clinical features predicted celiac in that population. The results belong to a well-established global pattern: IBS is one of the most common misdiagnoses celiac patients receive before their actual diagnosis.
What This Means for You
For celiac families, the IBS misdiagnosis story is familiar and frustrating. The average diagnostic delay for celiac disease runs six to ten years, and an IBS label is one of the most common detours along the way. Abdominal pain, bloating, diarrhea, constipation, and fatigue appear in both conditions. Without a celiac-specific blood test or biopsy, there is no clinical way to tell them apart.
The relevance of this research extends well beyond India. The IBS-celiac overlap is a global diagnostic problem. Studies from North America and Europe have consistently found that celiac disease is roughly three to four times more common in IBS populations than in the general public. Any research that sharpens the ability to identify which IBS patients are most likely to have celiac benefits gastroenterologists everywhere.
For parents of celiac children, or for any adult living with an IBS diagnosis, this study asks a pointed question: has celiac actually been ruled out? Not assumed away, but tested for with a blood draw and confirmed or excluded.
The specific clinical predictors identified in research like this give doctors a shortlist. Rather than screening every IBS patient, gastroenterologists can prioritize those who show the warning signs most strongly associated with underlying celiac—making earlier diagnosis more likely without requiring a blanket testing mandate.
Key Takeaways
- A notable share of patients diagnosed with IBS have undetected celiac disease; multiple studies worldwide—including this new prospective Indian study—support that finding.
- Celiac and IBS share symptoms closely enough that IBS is among the most common misdiagnoses celiac patients receive before the correct diagnosis.
- Certain clinical features—diarrhea-predominant symptoms, iron deficiency anemia, and unintentional weight loss—are associated with celiac disease in IBS populations and should prompt testing.
- A blood test (tissue transglutaminase IgA, or tTG-IgA) screens for celiac; intestinal biopsy confirms the diagnosis.
- If you or your child has an IBS diagnosis but has never been tested for celiac, ask a gastroenterologist to order the screening blood test.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
The IBS-Celiac Diagnostic Overlap
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder—it causes real symptoms but produces no visible structural damage to the gut. Gastroenterologists diagnose it using the Rome criteria, a standardized checklist of symptom patterns: recurrent abdominal pain, changes in stool frequency or consistency, and symptoms that shift with bowel movements. Crucially, the Rome criteria include no requirement to rule out celiac disease before assigning the IBS label.
Celiac disease is an autoimmune condition triggered by gluten, the protein found in wheat, barley, and rye. When someone with celiac consumes gluten, the immune system attacks the lining of the small intestine—specifically the villi, the tiny finger-like projections responsible for nutrient absorption. Over time, this immune response causes villous atrophy (flattening of the intestinal lining), impairing the gut’s ability to absorb nutrients normally.
The symptom overlap between the two conditions is substantial. Both cause abdominal pain, bloating, altered bowel habits, and fatigue. Neither shows up on standard imaging. Without celiac-specific blood tests or a biopsy, the two conditions are clinically indistinguishable—which is precisely how years of diagnostic delay happen.
What Predicts Celiac in IBS Patients?
The Rajasthan study used a prospective design—researchers enrolled new patients going forward rather than reviewing old records. This approach produces stronger evidence because it eliminates recall bias and allows standardized testing for every participant.
Participants met criteria for IBS and underwent systematic celiac screening: typically a tissue transglutaminase IgA (tTG-IgA) blood test followed by upper endoscopy with duodenal biopsy (a tissue sample from the first section of the small intestine) for those who screened positive. The duodenal biopsy remains the gold standard for celiac diagnosis because it directly shows whether villous atrophy is present.
Across studies in this area, the clinical features that most consistently predict celiac disease in IBS populations include:
- Diarrhea-predominant IBS (IBS-D): Celiac-related intestinal damage impairs absorption and produces loose stools more reliably than constipation-predominant patterns.
- Iron deficiency anemia: Villous atrophy limits iron absorption in the duodenum, making unexplained anemia a significant red flag.
- Unintentional weight loss: When the gut cannot absorb nutrients effectively, weight loss follows—even with adequate food intake.
- Family history of celiac disease: First-degree relatives of celiac patients carry a 10–15% lifetime risk. A sibling or parent with celiac substantially raises the probability.
- Younger age at symptom onset: Celiac that begins in childhood or early adulthood is often assigned other labels for years before the correct diagnosis arrives.
Why This Geographic Setting Matters—and Why the Lesson Is Universal
Northern India, including Rajasthan, has high per-capita wheat consumption and a significant burden of undiagnosed celiac disease. Earlier research from this region helped dismantle the outdated idea that celiac was a “Western disease”—it occurs wherever wheat is eaten, and Indian gastroenterologists have documented it extensively. A well-designed prospective study from this population adds a robust data point to global estimates.
The clinical takeaway, however, is not specific to India. Whether a patient is being evaluated in Chicago, London, or Jaipur, the same diagnostic gap exists: IBS can be assigned without ruling out celiac. The clinical predictors identified in studies like this one are valid across populations, and the screening test—a tTG-IgA blood draw—is inexpensive and widely available.
My son was diagnosed with celiac disease before he ever received an IBS label, which is not the experience of many celiac families. Plenty of celiac patients spend years being told their gut symptoms are functional—stress-related, anxiety-driven, or just IBS—before someone orders the right blood test. Research that sharpens the clinical profile of celiac-in-IBS makes it more likely that the next patient gets that test in year one instead of year eight.
If your child or anyone in your family carries an IBS diagnosis without ever being tested for celiac, bring it up at the next gastroenterology appointment. The screening test is straightforward. The difference in what comes next—a managed autoimmune condition on a gluten-free diet versus years of continued gut damage—is not.
References
Mayur D, Agarwal A, Birda CL. Prevalence and predictors of coeliac disease in patients with irritable bowel syndrome: A prospective study from Rajasthan, India. Tropical Doctor. 2026. PubMed